Aplasia cutis-myopia syndrome is a rare genetic condition that affects skin on the scalp and vision. People with aplasia cutis-myopia syndrome are born with small areas of missing skin on the scalp, and many develop severe nearsightedness in childhood. Some may also have eye structure changes and a higher risk of retinal problems, so regular eye care is important. The condition is lifelong, but vision and skin issues can be managed, and many people do well with treatment and monitoring. Care often includes protective scalp care, minor surgery for the skin areas if needed, and eye treatments such as glasses or contact lenses, with prompt care for any retinal symptoms.
Overview
Aplasia cutis-myopia syndromeSymptoms
Aplasia cutis-myopia syndrome features patches of missing skin present at birth, often on the scalp, that heal with thin scars or hairless areas. Early signs of Aplasia cutis-myopia syndrome also include marked nearsightedness in childhood and possible eye complications.
Outlook and prognosis
Most children with Aplasia cutis-myopia syndrome grow and learn with tailored support, though medical needs vary. Early eye care can slow vision changes, and careful skin and scalp management lowers infection risk. Regular check-ins with genetics and ophthalmology teams guide long‑term planning.
Causes and risk factors
Aplasia cutis-myopia syndrome typically results from a rare genetic change present from conception; it may be inherited or arise as a new mutation. Family history increases risk; environmental or lifestyle factors aren’t known causes, though prenatal health can influence complications.
Genetic influences
Genetics play a central role in Aplasia cutis-myopia syndrome, which is typically caused by inherited or new (de novo) changes in a single gene. Family history can increase risk. Genetic testing helps confirm diagnosis, clarify inheritance, and guide counseling.
Diagnosis
Doctors suspect Aplasia cutis-myopia syndrome from characteristic skin and eye findings and family history. The genetic diagnosis of Aplasia cutis-myopia syndrome is confirmed with targeted genetic tests, plus ophthalmic evaluation and, when needed, imaging to assess related features.
Treatment and drugs
Treatment for Aplasia cutis-myopia syndrome focuses on protecting and healing the scalp at birth, supporting vision, and monitoring growth and development. Care may include wound care, eye exams with glasses or contacts, and, when needed, surgery for scalp defects. Ongoing follow-up with dermatology, ophthalmology, and genetics helps tailor care over time.
Symptoms
People often notice two things in daily life: a small scalp area that didn’t fully form at birth and strong nearsightedness that shows up in childhood. Early features of Aplasia cutis-myopia syndrome include the scalp skin gap and early-onset myopia, which can affect school, sports, and reading. Features vary from person to person and can change over time. Regular eye care helps track changes and protect the retina.
A small round or oval area on the scalp is missing skin at birth. In Aplasia cutis-myopia syndrome, this spot is usually on the top or back of the head and may be covered by a thin membrane. It typically closes and heals over the first weeks to months.
As it heals, the area becomes a smooth, hairless patch or has thin, wiry hair around it. Many living with Aplasia cutis-myopia syndrome choose hairstyles, hats, or scarves for comfort or coverage. The skin can be a bit sensitive, so gentle care is helpful.
Distance vision is blurry, often starting in early childhood. In Aplasia cutis-myopia syndrome, prescriptions can be strong and may change as the eyes grow. Glasses or contact lenses usually sharpen vision well.
If one eye is much more nearsighted, the brain may favor the clearer eye. Clinicians call this amblyopia, which means one eye’s signal is used more than the other. Early treatment with glasses and patching can help.
How people usually first notice Aplasia cutis-myopia syndrome?
Many families first notice aplasia cutis–myopia syndrome at birth because a baby has one or more small, well-defined areas on the scalp where skin is missing, which may look like a shallow ulcer or a shiny scar. As the child grows, doctors and parents may pick up early vision issues—such as squinting, poor visual tracking, or signs of severe nearsightedness (high myopia)—during infancy or the first eye exams in early childhood. In some cases, an ultrasound during pregnancy hints at a scalp defect, but for many, the first signs of aplasia cutis–myopia syndrome are the scalp lesion at birth followed by early vision concerns.
Types of Aplasia cutis-myopia syndrome
Aplasia cutis–myopia syndrome is a rare, genetic condition. It links areas of missing skin at birth (usually on the scalp) with significant nearsightedness that can progress in childhood. Researchers describe a few clinical variants based on which gene is altered and the pattern of features, and this helps explain why symptoms can be milder in some families and more severe in others. Not everyone will experience every type.
Type 1 (ASC)
Features include small patches of missing scalp skin and moderate to high myopia that may worsen over time. This variant is often inherited in families and may come with subtle scalp scarring and hair pattern changes. Eye exams in early childhood are important to track vision and detect complications.
Type 2 (ASC with extra findings)
Along with scalp aplasia and high myopia, some have additional features like wider-set eyes or minor limb or facial differences. Symptoms can vary from mild to more noticeable differences, even within the same family. Regular checkups help tailor care to the individual pattern.
Autosomal recessive form
In some families, the condition appears when both parents carry a silent variant, and children may have more pronounced scalp defects and earlier, higher myopia. Some may also have eye structure differences that raise the risk of retinal issues. Early referral to dermatology and ophthalmology can reduce complications.
COL18A1-related variant
Changes in the COL18A1 gene can lead to aplasia cutis with significant myopia and, in some cases, retinal changes related to the eye’s supporting tissues. The skin areas may heal with noticeable scars, but they usually do not expand after infancy. Monitoring for retinal thinning or tears becomes a key part of care.
KRT/skin-structure variant
Variants affecting keratin or related skin-structure genes may present with larger or multiple scalp defects and myopia that shows up in early school years. Hair growth around healed areas can look patchy or tufted. People may notice different sets of symptoms depending on their situation.
Types of inheritance
Families can show either autosomal dominant or recessive patterns, which can influence how severe symptoms are and who is affected in each generation. In dominant families, myopia severity and scalp lesion size can differ widely from person to person. Discussing types of aplasia cutis–myopia syndrome with a genetics team can clarify personal risk and testing options.
What genetics can tell you about symptoms
Some people with Aplasia cutis–myopia syndrome inherit changes in the PAX6 gene, which can disrupt eye development and lead to severe nearsightedness and other vision problems. Variants affecting skin formation pathways can cause patches of missing scalp skin at birth that heal with scarring.
Causes and risk factors
Aplasia cutis-myopia syndrome usually stems from inherited gene changes present from conception. Families who have early symptoms of Aplasia cutis-myopia syndrome in one child face a higher chance in future pregnancies. It usually follows an autosomal recessive pattern, and parental relatedness raises risk. There are no known environmental or lifestyle causes, though healthy prenatal care and eye care may lower complications. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
When you’re expecting or planning, it’s natural to wonder what might raise the chances of a rare condition like aplasia cutis-myopia syndrome. Most risks that have been linked are about what happens in the womb—how blood flow, infections, or certain medicines influence early development. Two people with the same exposure can react very differently—biology shapes the response.
Exposure to methimazole or carbimazole early in pregnancy has been linked to aplasia cutis. This exposure could make the skin findings of aplasia cutis-myopia syndrome more likely.
Chickenpox infection in early pregnancy can disrupt skin and eye development. Varicella has been associated with localized skin absence at birth and may contribute to later nearsightedness.
Reduced blood flow to the fetus can lead to localized underdevelopment of tissues, including scalp skin. This vascular pathway has been linked to the combined features seen in aplasia cutis-myopia syndrome.
Loss of a co‑twin or twin‑to‑twin transfusion can abruptly alter fetal circulation. These events are associated with aplasia cutis and may raise the chance of aplasia cutis-myopia syndrome.
Genetic risk factors
Genetic risk in Aplasia cutis-myopia syndrome often involves changes in genes that guide scalp skin closure and eye growth before birth. Some risk factors are inherited through our genes. Understanding these patterns can guide family planning and help you act quickly on early symptoms of Aplasia cutis-myopia syndrome. In some families, the change is passed down; in others, it appears as a new, first-time change in the child.
Inheritance pattern: In many families with Aplasia cutis-myopia syndrome, the pattern appears autosomal dominant. Each child of an affected parent then has about a 50% (1 in 2) chance to inherit the gene change.
New (de novo) changes: Some children are the first in their family with the gene change. When testing shows a new change, parents usually have a low chance of it happening again.
Variable expressivity: In Aplasia cutis-myopia syndrome, features can range from a small scalp scar to marked short-sightedness. Even within one family, the mix and severity can differ.
Reduced penetrance: A person can carry the change yet show few or no clear features. This can make Aplasia cutis-myopia syndrome seem to skip generations.
Genetic heterogeneity: Evidence suggests more than one gene may be involved across different families. These genes tend to control early skin closure and eye growth.
Parental mosaicism: A parent can carry the change in some cells but not others and have very mild or no signs. This mosaic pattern can slightly raise recurrence risk even after a change appears new.
Missing or extra DNA: A small deleted or duplicated segment that includes a key gene can cause similar findings. These structural changes are another genetic route to the same features.
Testing and counseling: Genetic testing can look for the underlying change and clarify whether it was inherited or new. Results help estimate recurrence risk and guide screening for eye and scalp features in relatives.
Lifestyle risk factors
Lifestyle choices do not cause this condition, but they can influence scalp wound healing, eye comfort, and complications linked to high myopia. Understanding how lifestyle affects Aplasia cutis-myopia syndrome helps you reduce preventable risks. The following are lifestyle risk factors for Aplasia cutis-myopia syndrome that can shape day-to-day symptoms and longer-term outcomes.
Jarring activities like boxing, trampoline use, or basketball can increase vitreoretinal traction in high myopia, raising detachment risk. Choose lower-impact options like swimming, cycling, or walking and use protective eyewear.
Prolonged close-up reading or screen time can worsen eye strain and may contribute to myopia progression in children. Practice the 20-20-20 rule and encourage daily outdoor time to support visual comfort.
Excess sun can irritate scarred or grafted scalp areas and adds cumulative retinal light stress in myopic eyes. Wear hats, use scalp sunscreen once healed, and choose UV-protective lenses.
Nicotine and smoke impair skin perfusion and collagen repair, slowing healing at aplasia cutis sites. They also raise risks of retinal ischemia; quitting supports both scalp recovery and eye health.
Risk prevention
If you or your family are affected by Aplasia cutis-myopia syndrome, you can’t prevent the condition itself, but you can lower the chance of complications affecting the scalp and eyes. Prevention is about lowering risk, not eliminating it completely. Plans often focus on careful newborn skin care, early and regular eye care, and family planning options. Ask your care team what to watch for as early symptoms of Aplasia cutis-myopia syndrome so care starts promptly.
A genetics visit can explain how Aplasia cutis-myopia syndrome runs in families and your chances in future pregnancies. It can also review options like carrier testing, prenatal testing, or IVF with embryo testing.
If you’re pregnant or planning, discuss high‑risk obstetric care and delivery at a hospital with neonatal, dermatology, and eye specialists. This helps ensure rapid assessment of scalp defects and early eye checks after birth.
Keep any scalp opening from aplasia cutis clean, covered, and watched closely for healing. Early input from dermatology or plastic surgery can reduce infection and scarring risks.
Open scalp areas are more prone to germs, so careful wound hygiene and handwashing matter. Seek care quickly for redness, swelling, discharge, or fever to prevent deeper infection.
Transmission
Aplasia cutis-myopia syndrome is not infectious—you can’t catch it or spread it through everyday contact. It’s a genetic condition present from birth; in some families it is passed from parent to child, while in others it appears for the first time in a child because of a new gene change. Because reported cases are rare, the exact inheritance pattern can vary by family, so a genetics professional can explain the genetic transmission of Aplasia cutis-myopia syndrome and discuss personal risks for future pregnancies. Genetic testing may be considered to help clarify how Aplasia cutis-myopia syndrome is inherited in your family.
When to test your genes
Consider genetic testing if you or a close relative were born with aplasia cutis (scalp skin missing at birth), especially when paired with high myopia in childhood or adolescence. Testing is also reasonable before pregnancy or during family planning to clarify inheritance, recurrence risk, and options. If you already have these features, results can guide eye surveillance and supportive care.
Diagnosis
Aplasia cutis-myopia syndrome, also known medically as Knobloch syndrome, is usually identified by a mix of eye findings and a characteristic small area of missing skin on the back of the scalp at birth. Getting a diagnosis is often a turning point toward answers and support. Doctors confirm what they see on exam with focused eye testing and imaging, and then use genetic testing to make the diagnosis clear. In many cases, the genetic diagnosis of Aplasia cutis-myopia syndrome helps guide care for vision and any skull or brain differences.
Doctors look for a healed or scar-like patch of missing skin at the back of the scalp along with early, severe nearsightedness. This pattern strongly suggests Aplasia cutis-myopia syndrome when seen together.
An eye specialist measures how strong the nearsightedness is and checks the length and shape of the eyes. They also look for changes in the gel and retina that can happen with this condition.
Optical coherence tomography and wide-field photos help map the retina and look for weak areas or detachments. Ultrasound of the eye may be used if the view is cloudy.
MRI or CT can look for an occipital bone defect or a small encephalocele that sometimes accompanies this syndrome. Finding these features supports the diagnosis of Aplasia cutis-myopia syndrome.
Stages of Aplasia cutis-myopia syndrome
Aplasia cutis-myopia syndrome does not have defined progression stages. Its features tend to appear at different times—often a small area of missing scalp skin is present at birth, while severe nearsightedness and eye complications like retinal detachment can develop later—so it doesn’t follow a stepwise pattern. Doctors usually start with a conversation about birth findings, family history, and vision changes, then perform targeted exams of the scalp and eyes and may use imaging or genetic testing to confirm the diagnosis. Recognizing early symptoms of aplasia cutis-myopia syndrome—such as a small scalp defect at birth and early, high nearsightedness—can prompt timely referral to an eye specialist for monitoring and protection of vision.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially after learning about Aplasia cutis-myopia syndrome, which can involve areas of missing skin at birth along with severe nearsightedness and eye changes that raise the risk of retinal tears or detachment. Early care can make a real difference, particularly for eye health and scalp healing. For many, life expectancy appears near typical, but the long-term outlook often depends on how the eyes and any associated issues—like scarring, infections, or neurologic differences—are managed over time. People with Aplasia cutis-myopia syndrome may need frequent eye checks; catching early symptoms of retinal detachment, such as sudden flashes, new floaters, or a shadow in vision, can prevent lasting vision loss.
The outlook is not the same for everyone, but ongoing ophthalmology follow-up, protective eyewear, and prompt treatment of retinal problems can preserve vision for many years. Scalp defects often heal with care or surgical repair; once healed, they rarely affect day-to-day health, though some may choose procedures later for scarring. Serious complications, like infections from open scalp areas in infancy or untreated retinal detachments, are the main drivers of morbidity; with modern care, these risks can be lowered. Doctors call this the prognosis—a medical word for likely outcomes.
Looking at the long-term picture can be helpful. With ongoing care, many people maintain good overall health, attend school or work, and adapt routines to protect their eyes and skin. Mortality directly due to Aplasia cutis-myopia syndrome appears uncommon in published reports, but outcomes vary with the severity of eye disease and any additional medical concerns present in an individual. Talk with your doctor about what your personal outlook might look like, including how often to be seen by an eye specialist and what to do if sudden vision changes occur.
Long-term effects
For many, day-to-day life with aplasia cutis-myopia syndrome centers on vision and a small, hairless scalp patch. Long-term effects vary widely, and what one family sees may look different for another. High nearsightedness can progress in childhood and raises the lifetime chance of retinal problems. The long-term outlook for aplasia cutis-myopia syndrome often depends on the degree of eye involvement and whether any scalp or skull differences are present.
Nearsightedness often begins early and tends to remain high into adulthood. This can make distant details consistently blurry and limit activities that rely on crisp distance vision.
There is an increased chance of retinal tears or detachment over time. These events may bring sudden floaters, light flashes, or a curtain-like shadow in one eye.
The area of missing skin usually heals as a thin, hairless patch that stays visible as hair grows around it. In aplasia cutis-myopia syndrome, this patch typically remains stable over the years.
In some, the scalp patch overlies a small, congenital gap in the skull bone. This difference may be hard to notice from the outside later on, even if the bony gap itself persists.
How is it to live with Aplasia cutis-myopia syndrome?
Living with Aplasia cutis–myopia syndrome often means navigating two main challenges: caring for areas of missing or fragile scalp skin early on, and managing significant nearsightedness that can progress and raise the risk of retinal problems. Day to day, this can involve regular eye exams, protective eyewear, careful scalp and hair care, and sometimes procedures to support skin healing or appearance. Families and classmates may notice the visible scalp differences or thick glasses; clear communication, practical accommodations at school or work, and routine specialist follow-up can make a big difference. Many find that with consistent eye care and thoughtful skin protection, they can participate fully in school, work, and social life.
Treatment and drugs
Treatment for Aplasia cutis-myopia syndrome focuses on the specific features each person has, since the condition can affect the skin on the scalp and the eyes in different ways. Supportive care can make a real difference in how you feel day to day. Scalp defects are usually managed with careful wound care to prevent infection and support healing; small areas may heal on their own with dressings, while larger or deeper areas sometimes need surgical closure or grafting, and doctors may monitor the skull bones beneath. Eye care is essential: significant nearsightedness is corrected with glasses or contact lenses, and regular eye exams check for retinal thinning or detachment; if a detachment occurs, prompt retinal surgery can preserve vision. Your doctor may suggest genetic counseling for you and your family, and they may coordinate care among dermatology, ophthalmology, pediatrics, and surgery to adjust the plan as needs change.
Non-drug treatment
Living day to day with aplasia cutis-myopia syndrome often centers on caring for the scalp at birth and protecting vision as children grow. Early symptoms of Aplasia cutis-myopia syndrome may include a small area of missing scalp skin and trouble seeing distant objects, so supportive care starts early. Alongside medicines, non-drug therapies can guide wound healing, reduce scarring, and help preserve eyesight over time. Plans are tailored by dermatology, eye care, genetics, and therapy teams, with family education at the core.
Gentle cleaning and protective dressings help the scalp area close safely. Regular checks watch for infection and support healthy healing. Care plans change as the skin strengthens.
Sun protection and soft coverings can reduce irritation and discoloration over the healed spot. Massage and silicone-based scar care may improve flexibility and appearance over time.
A well-fitted protective cap or helmet can shield a fragile scalp during play. This is especially helpful while the area is still thin or healing. Your care team can advise when it’s no longer needed.
Regular eye exams track myopia and check the retina for weak spots, tears, or detachment. Urgent visits are needed for new flashes, floaters, or a curtain over vision.
Your genes may have an impact on how drugs work for you
For many with Aplasia cutis–myopia syndrome, genes can affect how the body processes medicines—changing speed, strength, and side‑effect risk. Clinicians may adjust drug type or dose and sometimes use pharmacogenetic testing to tailor safer, more effective treatment.
Pharmacological treatments
Day to day, care focuses on protecting sensitive scalp areas and preserving vision. Medicines for Aplasia cutis-myopia syndrome aim to prevent skin infection, ease discomfort, and slow the worsening of severe nearsightedness. Not everyone responds to the same medication in the same way. If you’re worried about early symptoms of Aplasia cutis-myopia syndrome, ask your care team which options fit your age, eye health, and skin needs.
Mupirocin or bacitracin ointment can lower the chance of infection on small, superficial scalp defects. Your clinician may advise short courses and spot application, especially in infants.
Plain white petrolatum (petroleum jelly) helps keep wounds moist and protected, which supports healing. It can be used with gentle daily cleansing as your clinician recommends.
If a scalp area becomes red, warm, and draining, doctors may prescribe cephalexin or amoxicillin‑clavulanate; for MRSA risk, clindamycin or trimethoprim‑sulfamethoxazole may be used. These are reserved for clear signs of infection, not routine prevention.
Acetaminophen or ibuprofen can ease tenderness from healing scalp areas when age-appropriate. Doses and timing should follow pediatric or adult guidance from your clinician.
Genetic influences
Evidence that Aplasia cutis-myopia syndrome can appear in more than one relative points to a genetic role. Researchers think the genetic causes of Aplasia cutis-myopia syndrome often trace to a change in a single gene that guides early development of scalp skin and the eyes, which can set the stage for both the scalp defect and nearsightedness. Family history is one of the strongest clues to a genetic influence. It can run in a family or arise as a new change in the gene for the first time in a child, and features can range from very mild to more noticeable even within the same family. Genetic testing may find the underlying gene change in a portion of cases, helping confirm the diagnosis and estimate the chance of recurrence. Knowing the inheritance pattern can help you and your care team plan, from testing at-risk relatives to discussing options for future pregnancies.
Is Aplasia cutis-myopia syndrome genetic?
Genetics play a central role in Aplasia cutis-myopia syndrome, which is typically caused by inherited or new (de novo) changes in a single gene. Family history can increase risk. Genetic testing helps confirm diagnosis, clarify inheritance, and guide counseling.
Pharmacogenetics—how genetics influence drug effects
Care for Aplasia cutis-myopia syndrome usually relies on careful wound care for the skin, eye treatments for high myopia, and pain control rather than a single, syndrome‑specific drug. There’s no evidence that the genetic changes causing Aplasia cutis-myopia syndrome directly change how the body breaks down most medicines, so doctors generally follow standard prescribing. Genetic testing can sometimes identify how your body processes certain medicines, which can help fine‑tune dosing if multiple drugs are needed. For pain after procedures or dressing changes, differences in drug‑processing genes can influence how well stronger pain medicines (opioids) work or what side effects you might have, and this can guide safer choices. Eye care may include atropine drops for myopia control; researchers are studying why some people respond more than others, but there isn’t a reliable genetic test to predict response yet. If medicines used to manage Aplasia cutis-myopia syndrome cause unusual side effects or don’t seem to help, let your care team know so they can consider alternatives, check for known drug–gene issues, and tailor treatment.
Interactions with other conditions
People with Aplasia cutis-myopia syndrome often see ripple effects when other health issues are in the mix. Early symptoms of Aplasia cutis-myopia syndrome, like an open area on the scalp, can be harder to manage if a skin condition such as eczema is present or if diabetes slows wound healing, raising the risk of infection. On the eye side, very high myopia can compound problems from other eye diseases—lattice degeneration, prior eye injury, or steroid-related eye pressure can further raise the chance of retinal tears or detachment. If surgery is needed for the scalp or eyes, bleeding disorders, certain blood thinners, or uncontrolled high blood pressure can add risk and call for closer planning. Talk with your doctor about how your conditions may influence each other. Because these interactions vary, coordinated care between dermatology, ophthalmology, and your primary team helps tailor choices about activity limits, protective eyewear, medications, and timing of procedures.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with small, sharply edged patches on the scalp that never quite formed skin, sometimes paired with striking nearsightedness later in childhood. Midwives wrote about carefully dressing these areas; parents learned to protect tender spots while hair grew around them. In school years, some children needed glasses unusually early and sat close to the board, clues that fit together only in hindsight.
First described in the medical literature as a pattern linking areas of missing skin at birth with high myopia, the condition gradually became known as Aplasia cutis-myopia syndrome. Early case notes focused on the visible scalp findings. Only later did follow‑up show that many of these children developed significant nearsightedness, helping clinicians connect skin and eye features that at first seemed unrelated. Over time, descriptions became more precise: the scalp lesions tended to be few and well‑defined, and the eye findings often appeared in the first decade of life.
From early theories to modern research, the story of Aplasia cutis-myopia syndrome reflects how different specialties meet in one diagnosis. Dermatologists documented where and how large the missing skin patches were; pediatricians tracked growth and healing; eye doctors reported the degree of myopia and, in some cases, related findings inside the eye. With each decade, small family reports and single cases added details, showing that while the core features were consistent, severity could vary—even within the same family.
In recent decades, knowledge has built on a long tradition of observation. Advances in genetics supported what families had long suspected: the tendency could run through generations, with some relatives showing mild scalp changes and others developing pronounced nearsightedness. This helped shift the view from a rare curiosity to a recognizable pattern that clinicians could look for early, guiding eye checks and skin care from infancy.
Understanding the history matters for people living with Aplasia cutis-myopia syndrome today. Knowing how the link between scalp findings and vision emerged explains why early symptoms of Aplasia cutis-myopia syndrome prompt both dermatology and eye referrals. It also underscores a practical lesson carried forward from past case reports: protecting healing scalp areas in infancy and monitoring vision in childhood can make everyday life safer and clearer.